611
Participants
Start Date
April 30, 2003
Primary Completion Date
May 31, 2004
Study Completion Date
May 31, 2004
Levitra (Vardenafil, BAY38-9456)
10mg Vardenafil for 4 weeks followed by an 8 week titration period when subjects may be titrated up to 20mg Vardenafil or down to 5mg Vardenafil followed by 14 weeks treatment at preferred dose.
Placebo
10mg placebo for 4 weeks followed by an 8 week titration period when subjects may be titrated up to 20mg placebo or down to 5mg placebo followed by 14 weeks placebo at preferred dose
Dublin
Dublin
Reading
Durham
Rhyl
Plymouth
London
Manchester
Manchester
Portsmouth
Northwood
Norwich
Belfast
Chipping Norton
Shrewsbury
Cardiff
Doncaster
Lichfield
Glasgow
Hamilton
Motherwell
Coventry
Leeds
Lead Sponsor
Bayer
INDUSTRY